Stratview Research has published a new report on the Glucose Monitoring System Market, segmented By Type (Sensors, Transmitters & Receivers, Integrated Insulin Pumps), End-User (Hospitals, Clinics, Home Healthcare), and Region.
This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global artificial intelligence as a service market.
Market Highlights
The Glucose Monitoring System market is projected to grow from USD 1.9 billion in 2020 to USD 2.7 billion by 2026 at a CAGR of around 6.1% during the forecast period.
To know more about the covid impact on the market, click here: https://www.stratviewresearch.com/Request-Sample/2390/Glucose-Monitoring-System-Market.html#form
Covid Impact
Covid-19 has impacted the market dynamics, competition, and global supply chain of every possible market one can think of. The revenues for many, have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operations and strategy will sustain and beat the competition.
Segmentation –
This report studies the Glucose Monitoring System Market and has segmented the market in a few ways, keeping in mind the concentration of all the stakeholders across the value chain. Following are the ways in which the market has been segmented in the report:
By end-user, the glucose monitoring system market has been bifurcated into hospitals, clinics, and home healthcare. Under these, the hospitals' segment accounted for the largest market share in 2020 and is projected to register significant growth during the review period. The segment growth can be attributed to the presence of established healthcare infrastructure, technical expertise, and professional healthcare staff.
By region, the market in North America accounted for the largest market share in 2020 and is projected to grow at a significant CAGR during the assessment period. The regional growth is primarily attributed to expanding geriatric populace and rising incidences of diabetes coupled with the presence of key market players such as Echo Therapeutics Inc. (US) and Insulet Corporation (US). The market growth in the Asia-Pacific region is expected to be driven by the increasing number of people having diabetes due to a sedentary lifestyle in developing countries, particularly China and India.
Following are the key players in the Glucose Monitoring System Market:
· Medtronic plc (Ireland)
· Abbott Laboratories (US)
· DexCom, Inc. (US)
· Echo Therapeutics Inc. (US)
· Insulet Corporation (US)
· Johnson & Johnson (US)
· Senseonics Holdings, Inc. (US)
· F. Hoffmann-La Roche AG (Switzerland)
· AgaMatrix Inc. (Germany)
· Glysure Ltd (UK)
· ORSENSE LTD (Israel)
· Ypsomed (Switzerland)
About Stratview Research-
Stratview Research is a global market intelligence firm having a strong team of industry veterans and research analysts. Stratview Research has been serving multiple clients across a wide array of industries. Our services cover a broad spectrum of industries including but not limited to Energy Chemicals, Advanced Materials, Automotive, and Aerospace. At Stratview, we believe in building long term relations with our clients.
Connect with our team here–
https://www.stratviewresearch.com/contact
Or
Call us @: +1-313-307-4176
glucose monitoring systems market
